Concepedia

Lisa LaGrandeur

LL

3

Publications

251

Citations

3

H-Index

1995

Active since

Affiliations

Eli Lilly (United States)(Current)

Lisa LaGrandeur is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and lipopeptides.

Top concepts

Publications per year

1995–2013

3

Publications

3

Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo

Virginia L. Stauffer, Brian A. Millen, Scott W. Andersen et al. · Schizophrenia Research · 2013 · 129 citations

, , +11

Semisynthetic Chemical Modification of the Antifungal Lipopeptide Echinocandin B (ECB): Structure-Activity Studies of the Lipophilic and Geometric Parameters of Polyarylated Acyl Analogs of ECB

Manuel Debono, William W. Turner, Lisa LaGrandeur et al. · Journal of Medicinal Chemistry · 1995 · 112 citations

, , +16

The Synthesis and Antifungal Activity of Nitrogen Containing Hemiaminal Ethers of LY303366.

James A. Jamison, Lisa LaGrandeur, Michael Rodriguez et al. · The Journal of Antibiotics · 1998 · 10 citations · Full text

Rows per page

1–3 of 3